Home > Boards > US Listed > Biotechs > PDL BioPharma Inc. (PDLI)

$PDLI Cowen Maintains Market Perform On PDL Biopharma

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
maytepper Member Profile
 
Followed By 25
Posts 1,430
Boards Moderated 0
Alias Born 01/18/11
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/19/2020 5:34:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2020 6:03:54 AM
PDL BioPharma Reports 2020 Third Quarter Financial Results and Sets Date To File a Certificate of Dissolution PR Newswire (US) - 11/11/2020 4:05:00 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 11/9/2020 5:09:03 PM
PDL BioPharma Reschedules Third Quarter 2020 Financial Results and Business Update PR Newswire (US) - 11/6/2020 5:26:00 PM
PDL BioPharma to Announce Third Quarter 2020 Financial Results and Provide a Business Update on November 9, 2020 PR Newswire (US) - 10/29/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/7/2020 4:02:33 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 10/5/2020 4:34:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/2/2020 8:36:25 AM
PDL BioPharma Completes Spin-Off of LENSAR PR Newswire (US) - 10/2/2020 8:30:00 AM
PDL BioPharma to Complete Spin-Off of LENSAR, Inc. on October 1, 2020 PR Newswire (US) - 9/10/2020 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2020 8:33:40 AM
PDL BioPharma Completes Divestiture of the Noden Pharmaceutical Business to Stanley Capital PR Newswire (US) - 9/9/2020 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/1/2020 6:04:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/31/2020 9:05:04 AM
PDL BioPharma Announces Sale of Kybella®, Zalviso® and Coflex® Royalties to SWK Holdings Corporation PR Newswire (US) - 8/31/2020 9:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 8/28/2020 4:54:15 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/28/2020 4:45:22 PM
Tender Offer Statement by Issuer (sc To-i) Edgar (US Regulatory) - 8/28/2020 8:42:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/28/2020 8:35:40 AM
PDL BioPharma Announces Offer to Purchase Convertible Notes Due 2021 and 2024 PR Newswire (US) - 8/28/2020 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/26/2020 9:03:19 AM
PDL BioPharma Announces Filing of a Form 10 Registration Statement with the Securities and Exchange Commission for a Potentia... PR Newswire (US) - 8/26/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2020 6:06:23 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2020 6:06:08 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences